- Antimicrobial
- A fast and powerful silver technology
- Under the supervision of a health care professional, KerraCel® Ag may be used for the management of acute and chronic, partial and full thickness wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, surgical wounds, traumatic wounds, first and second degree burns
|
Attribute Name
|
Value
|
|---|---|
|
Brand
|
Kerracel™
|
|
HCPCS Code
|
A6196, A6197, A6198, A6199
|
|
Overall Length (Imperial)
|
12 in, 16 in, 18 in, 2 in, 5 in, 6 in
|
|
Overall Length (Metric)
|
12.5 cm, 15 cm, 30 cm, 41 cm, 46 cm, 5 cm
|
|
Overall Width (Imperial)
|
0.75 in, 16 in, 2 in, 4 in, 6 in, 8 in
|
|
Overall Width (Metric)
|
10 cm, 15 cm, 2 cm, 20 cm, 41 cm, 5 cm
|
|
Pack Quantity
|
10 ea/bx, 5 ea/bx
|
- Antimicrobial
- A fast and powerful silver technology
This dressing is a gelling fiber silver dressing that uses the combination of an enhanced carboxymethyl cellulose (CMC) dressing and the advanced silver technology – Ag OXYSALTS™ Technology - to create the optimal wound healing environment.
This dressing is the only gelling dressing with Ag OXYSALTS™ Technology (Ag3+), providing up to 6 times more power than traditional silvers (Ag1+) *1:
- Kills bacteria within a biofilm and prevents biofilm re-formation*,2
- Quickly kills at least 99.999% (5 log) of a broad spectrum of bacteria*,3,4
A proven substrate, this dressing is a carboxymethyl cellulose (CMC) gelling fiber dressing designed to help create the optimal healing environment*:
- Quickly absorbs and locks away exudate and its harmful components5,6
- Micro-contours to the wound bed to eliminate dead space where bacteria can live7
- Designed to reduce the risk of periwound maceration6
- Strong enough to be removed in one piece8
*As demonstrated in vitro
1 Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Crawford Healthcare Ltd.
2 Evaluation of antimicrobial activity of KERRACEL™ Ag and Aquacel® Ag Extra™ against in vitro biofilms. CHC R541. 2017. Crawford Healthcare Ltd.
3 Antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against planktonic species over 7 days in vitro. CHC R539. 2017. Crawford Healthcare Ltd.
4 Rate of antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Crawford Healthcare Ltd.
5 Evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ sequester bacteria. CHC R543. 2017. Crawford Healthcare Ltd.
6 In vitro fluid handling properties of KERRACEL™ Ag and Aquacel® Ag Extra™. CHC R545. 2017. Crawford Healthcare Ltd.
7 Zone of inhibition evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ to uniformly kill planktonic bacteria. CHC R544. 2017. Crawford Healthcare Ltd.
8 An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Crawford Healthcare Ltd.
Ag OXYSALTS™ Technology is a trademark of Argent Limited Partnership
Suggested Applications
- Under the supervision of a health care professional, KerraCel® Ag may be used for the management of acute and chronic, partial and full thickness wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, surgical wounds, traumatic wounds, first and second degree burns
